US 11793806
Pyruvate kinase activators for use in therapy
granted A61KA61K31/415A61K31/4406
Quick answer
US patent 11793806 (Pyruvate kinase activators for use in therapy) held by Agios Pharmaceuticals, Inc. expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/415, A61K31/4406, A61K31/47, A61K31/496